ABL Diagnostics Confirms Its Change of Scale in the First Half of 2026: Revenue up 90.0%, EBITDA Multiplied by More Than Four and Net Income up 343.3% Compared to the First Half of 2025
This press release is being prepared.
The market announcement is already indexed, but the document has not finished syncing to our storage yet.